Clinical Trials Browser

Familial ependymoma, Congenital Abnormalities, Astrocytoma, Brain Neoplasms, Craniopharyngioma, Glioma, Leukemia, Leukemia, Hairy Cell, Leukemia, Mast-Cell, Medulloblastoma, Meningeal Neoplasms, Meningioma, Oligodendroglioma, Pinealoma, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Biphenotypic, Acute, Leukemia, Prolymphocytic, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Central Nervous System Neoplasms, Choroid Plexus Neoplasms, Neuroectodermal Tumors, Primitive, Optic Nerve Glioma, Leukemia, Large Granular Lymphocytic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

NCT01417507 2015-03-18

Natural History of Brain Function, Quality of Life, and Seizure Control in Patients With Brain Tumor Who Have Undergone Surgery

Completed

82 enrolled

CNS

Astrocytoma, Glioma, Oligodendroglioma, Seizures, Neurotoxicity Syndromes

NCT00003731 2012-09-24

Temozolomide in Treating Patients With Recurrent Oligodendroglial Tumors

Phase 2 Completed

39 enrolled

CNS

Glioma, Oligodendroglioma, Central Nervous System Neoplasms

NCT00039364 2012-07-24

Imatinib Mesylate in Treating Patients With Gliomas

Phase 2 Completed

112 enrolled

CNSSarcoma

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma, Central Nervous System Neoplasms, Glioma, Subependymal, Gliosarcoma

NCT00002840 2012-07-10

Radiation Therapy With and Without Combination Chemotherapy in Patients With Resected Anaplastic Oligodendroglioma

Phase 3 Completed

350 enrolled

CNS

Brain Neoplasms, Glioma, Oligodendroglioma, Central Nervous System Neoplasms

Clinical Trials

INCB7839 in Treating Children With Recurrent/Progressive High-Grade Gliomas

Selinexor in Treating Younger Patients With Recurrent or Refractory Solid Tumors or High-Grade Gliomas

Temozolomide and Radiation Therapy in Treating Patients With Gliomas

PBTC-047

Evaluate the Safety and Effectiveness of Intranasal Administration of Temozolomide in Patients With Glioblastoma

Ribociclib and Everolimus in Treating Children With Recurrent or Refractory Malignant Brain Tumors

Temozolomide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Anaplastic Oligodendrogliomas or Mixed Anaplastic Oligoastrocytomas

Topotecan in Treating Patients With Recurrent Brain Tumors

Hyperfractionated RT With BCNU Versus Conventional RT With BCNU for Supratentorial Malignant Glioma

Radiation Therapy Combined With Chemotherapy in Treating Patients With Anaplastic Astrocytoma or Mixed Gliomas

Remote Brain Microhaemorrhages May Predict Haematoma in Glioma Patients Treated With Radiation Therapy

TAVAREC

Radiation Therapy With or Without Chemotherapy in Treating Patients With Anaplastic Oligodendroglioma

Veliparib and Temozolomide in Treating Patients With Recurrent Glioblastoma

Radiation Therapy or Temozolomide in Treating Patients With Gliomas

Decision Making About Participating in Pharmacokinetic Studies in Patients Enrolled in a Phase I Treatment Clinical Trial

Natural History of Brain Function, Quality of Life, and Seizure Control in Patients With Brain Tumor Who Have Undergone Surgery

Temozolomide in Treating Patients With Recurrent Oligodendroglial Tumors

Imatinib Mesylate in Treating Patients With Gliomas

Radiation Therapy With and Without Combination Chemotherapy in Patients With Resected Anaplastic Oligodendroglioma